Cities hold the key: prioritizing equity in the COVID-19 recovery
Date:
16/04/2021
Cities were at the epicentre of the COVID-19 outbreak and have mounted a remarkable response. Urban centres now face the challenge of vaccine distribution. Speakers will highlight their response to the pandemic, steps to ensure equitable vaccine distribution and recovery, and how their policies can serve as models for governments and regions worldwide.
See more details
Coronavirus Infections/prevention & control, Pneumonia, Viral/prevention & control, Pandemics/prevention & control, Immunization Programs/organization & administration, Viral Vaccines/supply & distribution, Betacoronavirus/immunology, Coronavirus Infections/epidemiology, Pneumonia, Viral/epidemiology, Epidemiological Monitoring, Local Health Systems/organization & administration, Access to Essential Medicines and Health Technologies, Health Equity, Urban Health, 34658, Risk Groups, Health Communication, COVID-19
Live Q&A on COVID-19 and vulnerable populations with Dr Mike Ryan, Filippo Grandi, Teresa Zakaria
Date:
24/02/2021
See more details
Coronavirus Infections/immunology, Pneumonia, Viral/immunology, Pneumonia, Viral/prevention & control, Coronavirus Infections/prevention & control, Betacoronavirus/immunology, Pandemics/prevention & control, Viral Vaccines/supply & distribution, Epidemiological Monitoring, Health Communication, Social Isolation, Quarantine, Vulnerable Populations, Refugee Camps, Health Services Accessibility, Immunization Programs/organization & administration, COVID-19, Covax
WHO SAGE presenting its interim recommendations on the use of AstraZeneca Vaccine against COVID-19
Date:
10/02/2021
See more details
Coronavirus Infections/immunology, Pneumonia, Viral/immunology, Pneumonia, Viral/prevention & control, Viral Vaccines/immunology, Betacoronavirus/immunology, Epidemiological Monitoring, Health Communication, Viral Vaccines/supply & distribution, Vaccine Potency, Betacoronavirus/genetics, Mutation/genetics, DNA, Viral/genetics, Coronavirus Infections/genetics, Pneumonia, Viral/genetics, Risk Groups, COVID-19, AstraZeneca, Oxford
Live Q&A on COVID-19 virus variants & control measures with Dr Mike Ryan & Dr Maria Van Kerkhove.
Date:
17/03/2021
See more details
Epidemiological Monitoring, Betacoronavirus/genetics, Viral Vaccines/supply & distribution, Coronavirus Infections/genetics, Pneumonia, Viral/genetics, Mutation/genetics, DNA, Viral/genetics, Social Isolation, Health Communication, COVID-19
Live Q&A on COVID-19 with Dr Mike Ryan and Dr Maria Van Kerkhove
Date:
31/03/2021
See more details
Coronavirus Infections/epidemiology, Pneumonia, Viral/epidemiology, Pandemics/statistics & numerical data, Epidemiological Monitoring, Americas/epidemiology, Health Communication, Risk Groups, Immunization Programs/organization & administration, Betacoronavirus/immunology, Coronavirus Infections/immunology, Viral Vaccines/supply & distribution, Pneumonia, Viral/immunology, Antiviral Agents/therapeutic use, COVID-19
Media briefing on COVID-19 - 22/03/2021
Date:
22/03/2021
00:00:22
CL Good day and welcome wherever you are listening to us today. It's Monday 22nd March 2021. My name is Christian Lindmeier and I am welcoming you to today's global COVID-19 press conference. Simultaneous interpretation is provided in the six official languages, Arabic, Chinese, French, English, Spanish and Russian plus Portuguese and Hindi. Let me introduce the participants.
In the room...
See more details
Pandemics/prevention & control, Viral Vaccines/supply & distribution, Immunization Programs/organization & administration, Health Communication, Americas/epidemiology, Tuberculosis/prevention & control, Betacoronavirus/immunology, Coronavirus Infections/immunology, Pneumonia, Viral/immunology, Health Equity, Social Isolation, Quarantine, Masks, Schools/standards, COVID-19, Ghebreyesus, Tedros Adhanom , Covax
Media briefing on COVID-19 - 26/03/2021
Date:
26/03/2021
00:00:18
CL Hello. Good day to... wherever you are listening to us. Today is Friday 26th March 2021. My name is Christian Lindmeier and I'm welcoming you to today's global COVID-19 press conference. Simultaneous interpretation is provided in the six official UN languages, Arabic, Chinese, French, English, Spanish and Russian, as well as Portuguese and Hindi.
The participants today are, p...
See more details
Coronavirus Infections/prevention & control, Pneumonia, Viral/prevention & control, Pandemics/prevention & control, Viral Vaccines/supply & distribution, Immunization Programs/organization & administration, Health Communication, Risk Groups, Health Equity, Hospital Bed Capacity, Intensive Care Units, Americas/epidemiology, Betacoronavirus/genetics, Coronavirus Infections/genetics, Pneumonia, Viral/genetics, Viral Vaccines/immunology, Vaccine Potency, Mutation/genetics, DNA, Viral/genetics, COVID-19, Ghebreyesus, Tedros Adhanom , Covax
Media briefing on COVID-19 - 14/12/2020
Date:
14/12/2020
00:00:37
FC Hello, all. This is Fadela Chaib, speaking to you from WHO headquarters in Geneva and welcoming you to our global COVID-19 press conference today, Monday 14th December. We are happy to be joined today by representatives from youth organisations whom Dr Tedros will introduce to you. We will be talking about a new global initiative called Global Youth Mobilisation for Generation...
See more details
Coronavirus Infections/prevention & control, Pneumonia, Viral/prevention & control, Pandemics/prevention & control, Betacoronavirus/immunology, Viral Vaccines/supply & distribution, Personal Protective Equipment, Health Personnel/organization & administration, Drug Resistance, Microbial, Developing Countries, Schools, United Nations, Health Communication, Health Systems/organization & administration, Americas/epidemiology, Adolescent Health, Healthcare Financing, Universal Health Insurance, Quarantine/organization & administration, Mental Health, Social Isolation/psychology, Masks, COVID-19, Ghebreyesus, Tedros Adhanom, Big 6
Live: Dr Tedros' opening remarks at the Executive Board Special Session on COVID-19
Date:
05/10/2020
See more details
Betacoronavirus/immunology, Coronavirus Infections/diagnosis, Coronavirus Infections/epidemiology, Coronavirus Infections/immunology, Pneumonia, Viral/diagnosis, Pneumonia, Viral/epidemiology, Pneumonia, Viral/immunology, Pandemics/prevention & control, Pandemics/statistics & numerical data, Health Systems/organization & administration, Epidemiological Monitoring, Quarantine/organization & administration, Social Isolation, Personal Protective Equipment/supply & distribution, Healthcare Financing, Masks, Polymerase Chain Reaction/methods, Security Measures/organization & administration, Health Personnel/education, Health Human Resource Training, 50207, Strategic Stockpile/organization & administration, Viral Vaccines/immunology, Viral Vaccines/supply & distribution, Dexamethasone/therapeutic use, Health Communication, COVID-19, Ghebreyesus, Tedros Adhanom, Covax
Media briefing on COVID-19 - 24/08/2020
Date:
24/08/2020
See more details
Betacoronavirus/immunology, Coronavirus Infections/epidemiology, Pneumonia, Viral/epidemiology, Coronavirus Infections/immunology, Pneumonia, Viral/immunology, Viral Vaccines/immunology, Access to Essential Medicines and Health Technologies, Pandemics/prevention & control, Health Research Plans and Programs, Biomedical Research/economics, Health Personnel/organization & administration, Health Systems/organization & administration, Vulnerable Populations, Clinical Trial, Healthy Volunteers, Financing, Government/economics, Quarantine/organization & administration, Social Isolation, Epidemiological Monitoring, Masks, Coronavirus Infections/prevention & control, Pneumonia, Viral/prevention & control, Health Communication, COVID-19, Ghebreyesus, Tedros Adhanom, COVAX
